•
Since developing the first unique Occlutech occluder in 2003, over 50,000 ASD and PFO occluders have been delivered to over 80 countries around the world. Occlutech’s track record regarding performance and safety is excellent while we are still dedicated to innovating and constantly improving our products.
We are pleased to announce that our new website is now live! The site has been designed to give you a better support and experience. Enjoy.
The Occlutech support team provides comprehensive and professional answers to all your questions related to our products.
The development of minimally invasive septal occluders.
In the mid-seventies, Dr. Terry D. King and Dr. Noel I. Mills applied for a patent to protect their remarkable invention that allowed physicians to treat septum defects such as ASD or PFO without using open-heart surgery for the first time.
